Diabetes and ADHD drugs to be tested on Alzheimer's patients in new study - BBC
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
3 hours agoFergus WalshMedical editorBBCA clinical trial has been launched in the UK which scientists hope could cut years from the search for new treatments for Alzheimer's disease. It will test multiple drugs simultaneously, starting with two repurposed medicines already used to treat type 2 diabetes and attention deficit hyperactivity disorder (ADHD). The study will examine whether the drugs can lessen symptoms such as memory and thinking problems, and help people maintain their quality of life. Angela Bucksey, 67, from Cambridgeshire, was diagnosed with Alzheimer's in January and is the first person to begin treatment on the trial, called AD-SMART. "We have Alzheimer's in the family," she told the BBC. "My mother had it and my aunts, so it was a disappointment rather than a shock when I was diagnosed because I knew it would restrict my life. "But I was determined that it wasn't going to define me. "Angela said she felt empowered joining the trial because "at least you are doing something". "Instead of just sitting there, you're standing up and saying, I will fight back.
This article is an excerpt. To read the full content, visit the original source. BBC
Related articles
Regina mom hopes new HIV testing program will help others giving birth - CBC
SaskatchewanSaskatchewan is the first jurisdiction in Canada to use the rapid, on-site test in a widespread way and one of the first in the world to use it for determining best care for newborns based on viral loads of mothers, the manufacturer says.'Avant-garde' program can use viral loads of moms to help determine care for newborns in remote areasMaeve Ellis · CBC News · Posted: Oct 22, 2026 7:00 AM EDT | Last Updated: 1 hour agoListen to this articleEstimated 5 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Crystal Kay says she struggled to access prenatal care when she was pregnant and HIV-positive. (Richard Agecoutay/CBC)It was an agonizing wait, Crystal Kay says. "I gave natural birth to my kids, right? And there's blood involved, too. That's what kind of made me scared to pass it on to them. "Kay, who is HIV positive, said she had trouble accessing prenatal care and didn't know her viral load before giving birth in Regina. She had to wait days to get her results after taking the test in the hospital, she recalled.
Halifax conference highlights research on PTSD and brain injury impacts for the sake of Canadian veterans - PNI Atlantic News
Skip to Content Home Filter by region Nova Scotia Halifax Local Sports Local Business Local Opinion Annapolis Valley Truro Tri-County New Glasgow South Shore Antigonish Cape Breton Prince Edward Island Summerside Newfoundland & Labrador News Canada Health World Opinion Editorial Cartoons Business Local Business Sports Local Sports Baseball Basketball Football Hockey Entertainment & Life Food Homes Savings Special Sections Lives Told Tails Told Shopping Essentials Deals Entertainment & Hobbies Gift Guide Home Living Kitchen & Dining Outdoor Living Personal Care Style & Beauty Tech Travel Guide PNI Atlantic Store ePaper Puzzmo Newsletters Travel Business Ads Obituaries Classifieds Jobs Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Profile Settings My Subscriptions Newsletters Customer Service FAQ News Opinion Business Sports Entertainment & Life Special Sections Shopping Essentials ePaper Puzzmo Newsletters Travel Business Ads Obituaries Classifieds Jobs HomeAtlantic CanadaNewsNova ScotiaHalifaxHalifax conference highlights research on PTSD and brain injury impacts for the sake of Canadian veterans'We all need to come together to do
‘It’s emotional, but it’s a good thing’: Free Parkinson’s-exercise program makes its way to Regina - CTV News
AtlanticNova ScotiaNew BrunswickPrince Edward Island Newfoundland and LabradorCalgaryLethbridgeKitchenerGuelphNorthern OntarioSudburyNorth BaySault Ste. MarieTimminsOttawaKingstonBrockvillePembrokeReginaYorktonSaskatoonPrince AlbertTorontoWatchWeatherPeelHamiltonDurhamYorkHaltonNiagaraQueen's ParkToronto City HallIn PicturesVancouverVancouver IslandCanadaLocal SpotlightRoyal FamilyPoliticsNanosPower PlayQuestion PeriodFederal Election 2025WorldMideast ConflictRussia-Ukraine WarWatchLatestCaptured on CameraPoliticsLifestyleConsumerHealthExplainedEntertainmentTechnologyDeception DecodedAutosEnvironmentBusinessInflationReal EstateAutos
Low prevalence of celiac disease in French children, a nationwide study - Nature
ORCID: orcid.org/0000-0001-5425-73521,3,5 AbstractBackgroundThere are differences in prevalence and incidence across Europe without updated data for France. The aim of this study was to fill this gap obtaining epidemiological data of French children with celiac disease (CD). MethodsWe used the French Health Data System (SNDS) to identify <18-year-old patients with CD between 2011 and 22. CD identification: 1/hospitalization stay for CD, or 2/ status of CD as long-term disease, or 3/serological diagnosis (two tests for transglutaminase antibodies (TGA) within 13 months and one endomysium antibodies (EMA) test within seven months after a TGA test). Results41690 children with CD were identified over 2011–2022. The male-to-female sex ratio was 0.88. In 2022, the national prevalence was 0.15% among children, ranging from 0.08% in the North-West to 0.25% in the South-East of France. The incidence rate ranged from 12.4 in 2020 to 17.4 per 100000 children in 2012, with a median age increasing from six in 2011 to seven in 2015. Comorbidities included thyroid disease (1.7%), and type 1 diabetes (9.7%).
0 comments
No comments yet. Be the first to share your thoughts!